Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd., commonly referred to as Chia Tai-Tianqing, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Jiangsu, China. Established in 1994, the company has made significant strides in developing innovative pharmaceutical products, focusing on areas such as oncology, cardiovascular health, and infectious diseases.
With a robust portfolio that includes both generic and proprietary medications, Chia Tai-Tianqing is recognised for its commitment to quality and research-driven solutions. The company has achieved notable milestones, including various certifications and partnerships that enhance its market position. As a leader in the pharmaceutical sector, Chia Tai-Tianqing continues to expand its operational footprint, contributing to healthcare advancements both domestically and internationally.
-16 vs industry average
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd’s score of 26 is lower than 38% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd, a pharmaceutical preparation manufacturer headquartered in CN, reported approximately 189.5 million kg CO2e in total emissions for 2019. This data was inherited from the ultimate parent company through a corporate family relationship, with Sino Biopharmaceutical Limited identified as the source for CDP data at a cascade level of 1. In the previous year, 2018, the company's total emissions were approximately 120.4 million kg CO2e. The disclosed emissions data for both years do not specify Scope 1, Scope 2, or Scope 3 breakdowns. There are no publicly available specific reduction targets or climate commitments for Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd at this time.
No climate goals have been disclosed for Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more